Today, I am highlighting three biotech/healthcare stocks that currently trade under $10 a share after some recent weakness. I am slowly accumulating each of these names on these dips, both straight ...

This newly issued patent strengthens SINTX’s intellectual ... Smart Investor: Why the Bond Selloff May Be Good News, Will the Fed Still Cut Rates, and What’s Next for the AI Trade.

The good news is biosolutions can help. Biosolutions – biological technologies that use enzymes, microbes and functional ...

Tonner Drones Answers Questions From Shareholders Schiltigheim, February 21th 2025 8:00, Tonner Drones (’the Company’) today publishes the answers to questions it has received from shareholders in the ...

Global Patent Filings: Accelerating Commercial ... BioNxt is advancing regulatory approvals and commercialization efforts, primarily focused on European markets. BioNxt is committed to improving ...

Investors should always do their due diligence because you never ... suggesting that management is running a good business and has the flexibility to continue investing in it.

Operator Good morning, and welcome to the Axsome Therapeutics fourth quarter and full year 2024 conference call. Currently, all participants are in listen-only mode. Later, there will be a ...

The increase was primarily related to commercialization ... uptake will look like, but I do think that those are probably the closest analogs to assess. Hi, good morning. Thanks for taking our ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.

ImmunityBio, Inc. , a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative ...

for Patent & Commercialization from Department of Industrial Policy and Intellectual Property Office, Government of India in association with the Confederation of Indian Industry -Tejas Networks ...

Patents require reliability so they can incentivize investments in new technologies, their primary though little-noticed ...